Latest Posts:
External Control Arms Based on Real World Data: MHRA Consultation Opens
The EU AI Act and Medical Devices: Innovation or Insanity Ahead?
New White House Executive Order to Establish “Most-Favored-Nation” Drug Pricing
US Tariffs and the Life Science industry – an update
The Healthcare Agenda of Germany’s New CDU/SPD Coalition Government – A Point-by-Point Analysis of Key Policies and Their Potential Implications for Pharma and Med-Tech Companies
Switzerland’s Therapeutic Products Act Revision: Industry Stakeholders Show Positive Support
European Commission Proposes Act to Secure Critical Medicines Supply but has Wider Ambitions for Improved Accessibility of Other Medicinal products by Creating a Framework for Collaborative Procurement
The Impact of Tariffs on the Life Sciences Industry
Search for:
Focus Areas
Digital Health
EU Pharmaceutical Package
Health Data Privacy & Security
Healthcare Services
Medical Devices
Pharmaceuticals & Biotech
Search for:
Author
Patrick O'Gara
Browsing
Focus Areas
Digital Health
EU Pharmaceutical Package
Health Data Privacy & Security
Healthcare Services
Medical Devices
Pharmaceuticals & Biotech